Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

Interpace Diagnostics Gr Q3 EPS $(1.54) Down From $(0.19) YoY, Sales $8.20M Up From $7.72M YoY

Author: Benzinga Newsdesk | January 20, 2021 09:32am
Interpace Diagnostics Gr (NASDAQ:IDXG) reported quarterly losses of $(1.54) per share. This is a 710.53 percent decrease over losses of $(0.19) per share from the same period last year. The company reported $8.20 million in sales this quarter. This is a 6.15 percent increase over sales of $7.72 million the same period last year.

Posted In: IDXG


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist